An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature Sumanta Kumar PalKathleen BlazerGeorge Somlo Review 26 May 2008 Pages: 1 - 5
Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival Andrea C. BaffordHarold J. BursteinMehra Golshan Review 26 June 2008 Pages: 7 - 12
Role of melatonin in the epigenetic regulation of breast cancer Ahmet KorkmazEmilio J. Sanchez-BarceloRussel J. Reiter Review 01 July 2008 Pages: 13 - 27
PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity Jie GaoGeng KouYajun Guo Preclinical Study 15 May 2008 Pages: 29 - 41
Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy Wensheng LiuMargot M. IpGokul M. Das Preclinical Study 15 May 2008 Pages: 43 - 50
Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives A-Yong CaoJuan HuangZhi-Ming Shao Preclinical Study 16 May 2008 Pages: 51 - 55
Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells S. HiscoxN. J. JordanR. I. Nicholson Preclinical Study 21 May 2008 Pages: 57 - 67
A common Greenlandic Inuit BRCA1 RING domain founder mutation Thomas v. O. HansenBent EjlertsenFinn C. Nielsen Preclinical Study 26 May 2008 Pages: 69 - 76
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome Malini HarigopalJonas HeymannDavid L. Rimm Preclinical Study 03 June 2008 Pages: 77 - 85
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer G. FountzilasU. DafniH. P. Kalofonos Clinical Trial 16 May 2008 Pages: 87 - 99
Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902 Johanna G. H. van NesHein PutterCooperating Investigators of the EORTC Clinical Trial 18 May 2008 Pages: 101 - 113
Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer Maura N. DicklerMelody A. CobleighEric P. Winer Clinical Trial 22 May 2008 Pages: 115 - 121
The impact of sharing results of a randomized breast cancer clinical trial with study participants Ann H. PartridgeA. C. WolffE. P. Winer Clinical Trial 10 June 2008 Pages: 123 - 129
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer Alessandra GennariMichele De TursiStefano Iacobelli Clinical Trial 13 September 2008 Pages: 131 - 136
Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures Mostafa SaadatMaryam Ansari-Lari Epidemiology 15 May 2008 Pages: 137 - 144
The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis Sharon E. JohnattyJonathan BeesleyThe Kathleen Cuningham Consortium for Research in Familial Breast Cancer Epidemiology 15 May 2008 Pages: 145 - 150
Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics Lina MuDionyssios KatsarosHerbert Yu Epidemiology 15 May 2008 Pages: 151 - 162
Ethnic differences in the use of regular mammography: the multiethnic cohort Quannetta T. EdwardsArthur X. LiRoberta McKean-Cowdin Epidemiology 21 May 2008 Pages: 163 - 170
Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition Laura BagliettoDallas R. EnglishGraham G. Giles Epidemiology 29 May 2008 Pages: 171 - 179
Screening caused rising incidence rates of ductal carcinoma in situ of the breast L. N. van SteenbergenA. C. VoogdL. V. van de Poll-Franse Epidemiology 31 May 2008 Pages: 181 - 183
No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study Timothy R. RebbeckAntonis C. AntoniouDouglas F. Easton Epidemiology 04 June 2008 Pages: 185 - 192
Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points Bilal MajedThierry MoreauCurie Institute Breast Cancer Group Epidemiology 12 June 2008 Pages: 193 - 203
Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer? S. J. BeyerR. E. JimenezS. M. Jhiang Brief Report 26 May 2008 Pages: 205 - 212
Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland M. WangB. YuL. Hilakivi-Clarke Brief Report 31 May 2008 Pages: 213 - 220